Clinical Solutions for Medical Devices, IVD and CDx
End-to-end clinical support for MedTech innovators
End-to-end clinical support that helps MedTech innovators move from early strategy to regulatory-ready execution — with confidence, speed and compliance. We support medical device, IVD and CDx developers with integrated clinical strategy, study design and trial execution.
End-to-end clinical delivery
From gap assessment to full CRO delivery, we support medical device, IVD and CDx developers with integrated clinical strategy, study design and trial execution.
Clinical Trial Application
Our experts ensure clinical evidence meets MDR, IVDR and performance evaluation requirements, without late-stage surprises.
Focused expertise for MedTech innovators
As a full-service CRO, we guide you from early evidence planning through clinical operations and post-market activities.
Industry context
What Are the Biggest Clinical Solutions for Medical Devices, IVD and CDx Challenges?
At QbD Group, we deliver clinical development and validation for MD, IVDs and CDx, combining high-quality gap assessments, expert medical writing and full-service CRO execution.
Whether you're preparing a first clinical investigation, generating post-market evidence, or navigating the complexities of companion diagnostic co-development, our multidisciplinary team ensures your clinical program is designed for regulatory success from day one.
Our services
Which Industries Do We Support With Clinical Solutions for Medical Devices, IVD and CDx?
CRO Services
Why QbD Group
Why Choose QbD Group for Clinical Solutions for Medical Devices, IVD and CDx?
We support MedTech companies with regulatory expertise across MDR, FDA, IVDR, ISO 14155, ICH-GCP, and our close collaboration with Notified Bodies, enabling trust, transparency, and faster outcomes.
MedTech expertise
focused exclusively on medical devices, IVD and companion diagnostics.
Trusted partner
proven track record with innovators and established MedTech companies alike.
Quality at every step
rigorous processes ensure clinical evidence that meets regulatory expectations.
Right-sized solutions on budget
we scale our services to match your project needs and timeline.
CIR accreditation 2026 to 2028
CIR-accredited research partner in France
QbD Group is accredited by the French Ministry of Higher Education, Research and Space as a research organisation under the Crédit d'Impôt Recherche (CIR) scheme for 2026 to 2028. Eligible R&D services you subcontract to QbD Group can therefore be included in your CIR declaration.
This applies to French companies, and to foreign companies with a subsidiary or permanent establishment in France, that are eligible for the CIR scheme.
Contact us